Viewpoint: Blood tests for cancer would be ‘less invasive, less expensive, less traumatic’

Print Friendly, PDF & Email
3-24-2019 michigan med l liquid biopsy
Image credit: University of Michigan

Eleven years ago, I was shocked to be diagnosed with advanced lymphoma. To offer an informed second opinion, an oncologist recommended that I have a standard-of-care CT-guided thoracic biopsy. The goal was to collect a tissue sample from one of the nodules on my lung.

I hope I never have to undergo a biopsy like that again. It’s why I’m incredibly excited at the prospect of what are being called liquid biopsies. These are essentially blood tests used to collect a sample of cancer cells or pieces of DNA from them.

The complications [of traditional biopsies], which included a collapsed lung, pulmonary hemorrhage, infection and, in rare cases, being admitted to the hospital or dying, sounded scary for a biopsy.

Related article:  Treating genetic disorders before birth? CRISPR cures mouse disease in the womb

[I] wish there was a faster, less invasive, less expensive, less traumatic way of collecting tissue.

I imagine what would have happened if I could have had a liquid biopsy instead of the traditional one: no overnight fast or trip to New York. Less (or no) time off from work for me and my care partner. No panic attack, no partially collapsed lung, no pain or coughing up blood.

Read full, original post: Liquid biopsy research should include the perspectives of patients like me

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists